Cytosorbents Corporation (CTSO) Social Stream
CYTOSORBENTS CORP (CTSO) Price Targets From Analysts
Use the tables below to see what analysts covering CYTOSORBENTS CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-19 | 6 | $16 | $10 | $12.666 | $1 | 1166.6% |
| 2022-01-24 | 6 | $16 | $5 | $11 | $1 | 1000% |
| 2022-03-09 | 6 | $16 | $5 | $10.666 | $1 | 966.6% |
| 2022-04-18 | 6 | $16 | $5 | $10.166 | $1 | 916.6% |
| 2022-05-04 | 6 | $16 | $5 | $9.666 | $1 | 866.6% |
| 2022-05-05 | 6 | $16 | $5 | $8.833 | $1 | 783.3% |
| 2022-08-03 | 4 | $16 | $8 | $11 | $1 | 1000% |
| 2022-10-06 | 4 | $16 | $7.5 | $10.125 | $1 | 912.5% |
| 2022-11-03 | 4 | $16 | $6.5 | $9.875 | $1 | 887.5% |
| 2023-02-01 | 4 | $16 | $5.5 | $9 | $1 | 800% |
| 2023-02-15 | 4 | $16 | $5.5 | $8.875 | $1 | 787.5% |
| 2023-08-03 | 4 | $16 | $5.5 | $8.4 | $1 | 740% |
| 2023-11-13 | 5 | $16 | $4 | $7.666 | $1 | 666.6% |
| 2023-11-16 | 5 | $10 | $4 | $6.333 | $1 | 533.3% |
The Trend in the Analyst Price Target
CTSO's average price target has moved down $7.17 over the prior 27 months.
Over the past 41 weeks, CTSO's average upside potential has been 262.65%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-03 | 4 | 16 | 5.5 | 8.400 | 3.29 | 155.32% |
| 2023-05-03 | 4 | 16 | 5.5 | 8.400 | 2.76 | 204.35% |
| 2023-11-13 | 5 | 16 | 4.0 | 7.666 | 1.29 | 494.26% |
| 2023-11-16 | 5 | 16 | 4.0 | 7.333 | 1.10 | 566.64% |
| 2023-11-16 | 5 | 10 | 4.0 | 6.333 | 1.10 | 475.73% |
CTSO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 15 months, CTSO's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CTSO as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, CYTOSORBENTS CORP's upside potential (average analyst target price relative to current price) is greater than 1640.86% of them.
- CTSO has a greater average analyst price target than 173.14% of all US stocks.
- In terms of how CYTOSORBENTS CORP fares relative to Medical Equipment stocks, note that its variance in analysts' estimates is lower than -1426.16% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, CYTOSORBENTS CORP's number of analysts covering the stock is higher than 423.21% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to CYTOSORBENTS CORP are KRMD, NMRD, and PLSE.
View All Top Stocks by Price Target
What is the outlook for CTSO? Use POWR Ratings for clearer insight into price direction.